Skip to main content
. 2022 Nov 24;12:1046584. doi: 10.3389/fonc.2022.1046584

Figure 7.

Figure 7

Survival analysis. Disease-free survival (A) and overall survival (B) among patients with different treatment response to combinational therapy evaluated via preoperative MR imaging (mRECIST). Disease-free survival (C) and overall survival (D) between patients who did and did not achieve a pathological complete response (pCR) in all resected specimens. Disease-free survival (E) and overall survival (F) between patients with and without microvascular invasion (MVI) in resected tumor samples.